Study highlights vitiligo positive news
A team of researchers in Japan has reached a new understanding of vitiligo, discovering that the pigment cells do not completely die in affected areas. Instead, they enter a state of dormancy during which they lose their ability to produce melanin. These cells depend on their connection to a basal membrane and the protein laminin-211, but in vitiligo patients, levels of laminin-332 increase. This change alters the type of connection and forces the cells to activate biological pathways that push them into a dormant state, leading to the appearance of white patches. Studies have shown that medications targeting these pathways can reactivate the pigment cells and restore pigmentation. This represents an important step in understanding the disease and opens new therapeutic avenues focused on restoring cell function rather than solely suppressing immune inflammation.
Notice: This Is an AI-Generated Summary
Comments (0)